SCHEMBL750120

SCHEMBL750120

O=C(O)N1CCCC1c1nc2c([nH]1)-c1ccc(Br)cc1CC2

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 13/20 0.41
HCRTR2 O43614 13/20 0.41
TYMS P04818 1/20 0.39
SRD5A1 P18405 1/20 0.38
SRD5A2 P31213 1/20 0.38
SCD5 Q86SK9 1/20 0.36
CDC7 O00311 1/20 0.35
PIM1 P11309 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PRCP P42785 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL883263 0.86 UCHL1 (0.40) HCRTR1HCRTR2TYMSALDH1A1MAPT
SCHEMBL203624 0.86 UCHL1 (0.40) HCRTR1HCRTR2TYMSALDH1A1MAPT
SCHEMBL10232536 0.85 AADAT (0.43) HCRTR1HCRTR2NPSR1
SCHEMBL10182470 0.83 CDC7 (0.48) TYMSSRD5A1CDC7PIM1CSNK2B
SCHEMBL22361272 0.82 HCRTR1 (0.36) HCRTR1HCRTR2PRCP
SCHEMBL6126794 0.82 HCRTR1 (0.36) HCRTR1HCRTR2PRCP
SCHEMBL14742976 0.82 UCHL1 (0.40) HCRTR1HCRTR2ALDH1A1MAPTKMT2A
SCHEMBL14742974 0.82 UCHL1 (0.40) HCRTR1HCRTR2ALDH1A1MAPTKMT2A
SCHEMBL2709197 0.81 CYP3A4 (0.59)
SCHEMBL6126089 0.80 HCRTR1 (0.32) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104016971-B Antiviral compound PHARMASSET INC. (US) 2016-05-25 CN disclosed
CN-103977406-A Antiviral compounds GILEAD SCIENCES INC 2014-08-13 CN disclosed
EP-2640719-A2 ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2013-09-25 EP disclosed
WO-2012068234-A2 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2012-05-24 WO disclosed
EP-2430014-A1 ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2012-03-21 EP disclosed
WO-2010132601-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-11-18 WO disclosed